Impedimed Ltd (IPD) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.053x

Based on the latest financial reports, Impedimed Ltd (IPD) has a cash flow conversion efficiency ratio of -1.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.50 Million ≈ $-6.72 Million USD) by net assets (AU$9.02 Million ≈ $6.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Impedimed Ltd balance sheet independence to measure how much of total assets are equity-financed.

Impedimed Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Impedimed Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore how much of Impedimed Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Impedimed Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Impedimed Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Till Capital Ltd V:TIL	-0.014x
Pacific Assets Trust plc LSE:PAC	0.000x
NuCana PLC NASDAQ:NCNA	-0.038x
Biofil Chemicals & Pharmaceuticals Limited NSE:BIOFILCHEM	-0.167x
Hybrid Financial Services Limited NSE:HYBRIDFIN	0.025x
Farlim Group (Malaysia) Bhd KLSE:6041	-0.019x
S-Energy Co.Ltd KQ:095910	-0.051x
Rathdowney Resources Ltd V:RTH	0.013x

Annual Cash Flow Conversion Efficiency for Impedimed Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Impedimed Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Impedimed Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$20.50 Million ≈ $14.50 Million	AU$-14.64 Million ≈ $-10.36 Million	-0.715x	-63.65%
2024-06-30	AU$40.74 Million ≈ $28.83 Million	AU$-17.79 Million ≈ $-12.59 Million	-0.437x	-47.27%
2023-06-30	AU$60.88 Million ≈ $43.08 Million	AU$-18.05 Million ≈ $-12.77 Million	-0.296x	+3.39%
2022-06-30	AU$51.04 Million ≈ $36.12 Million	AU$-15.66 Million ≈ $-11.08 Million	-0.307x	+40.94%
2021-06-30	AU$25.51 Million ≈ $18.05 Million	AU$-13.26 Million ≈ $-9.38 Million	-0.520x	+26.02%
2020-06-30	AU$27.36 Million ≈ $19.36 Million	AU$-19.22 Million ≈ $-13.60 Million	-0.702x	+43.40%
2019-06-30	AU$15.79 Million ≈ $11.17 Million	AU$-19.59 Million ≈ $-13.86 Million	-1.241x	-89.40%
2018-06-30	AU$35.80 Million ≈ $25.33 Million	AU$-23.46 Million ≈ $-16.60 Million	-0.655x	-50.68%
2017-06-30	AU$58.80 Million ≈ $41.60 Million	AU$-25.57 Million ≈ $-18.09 Million	-0.435x	-65.33%
2016-06-30	AU$85.25 Million ≈ $60.32 Million	AU$-22.42 Million ≈ $-15.86 Million	-0.263x	+14.83%
2015-06-30	AU$34.84 Million ≈ $24.65 Million	AU$-10.76 Million ≈ $-7.61 Million	-0.309x	+38.57%
2014-06-30	AU$13.53 Million ≈ $9.57 Million	AU$-6.80 Million ≈ $-4.81 Million	-0.503x	+30.62%
2013-06-30	AU$10.59 Million ≈ $7.50 Million	AU$-7.67 Million ≈ $-5.43 Million	-0.724x	-6.30%
2012-06-30	AU$17.31 Million ≈ $12.25 Million	AU$-11.80 Million ≈ $-8.35 Million	-0.682x	-24.75%
2011-06-30	AU$20.68 Million ≈ $14.63 Million	AU$-11.30 Million ≈ $-7.99 Million	-0.546x	-16.93%
2010-06-30	AU$22.23 Million ≈ $15.73 Million	AU$-10.39 Million ≈ $-7.35 Million	-0.467x	+60.09%
2009-06-30	AU$10.07 Million ≈ $7.12 Million	AU$-11.79 Million ≈ $-8.34 Million	-1.171x	-94.18%
2008-06-30	AU$12.30 Million ≈ $8.70 Million	AU$-7.42 Million ≈ $-5.25 Million	-0.603x	--

About Impedimed Ltd

AU:IPD Australia Medical Devices

Market Cap

$5.77 Million

AU$8.15 Million AUD

Market Cap Rank

#28288 Global

#1475 in Australia

Share Price

AU$0.00

Change (1 day)

-20.00%

52-Week Range

AU$0.00 - AU$0.05

All Time High

AU$1.68